临床1期肾细胞癌微波消融后的CT与MR影像监测
单中心回顾性研究纳入49例cT1a和19例cT1b肾细胞癌患者共71个病灶,经皮微波消融后行CT和MRI监测。消融区呈T1WI不均匀高信号、T2WI低信号、CT高密度,周边薄环状强化提示成功;消融区局部强化软组织提示局部复发,T1b复发率11%(2/19)高于T1a的2%(1/52)。
要点
- 消融后即刻CT见包膜下积气和血肿(5/71,7%)在首次随访前吸收。
- 消融区周边薄环状强化但内部无强化提示消融成功。
- 消融区内沿肾缘的局灶强化软组织提示局部复发,T1b复发率高于T1a。
关键影像表现/征象
- 消融区在T1WI上呈不均匀高信号,T2WI上呈低信号,CT上呈高密度。
- 消融区周边薄环状强化而内部无强化提示消融成功。
- 消融区在监测期间缩小但未完全消失。
- 消融后即刻包膜下积气和血肿(5/71,7%)在首次随访前吸收。
- 消融区内沿肾缘的局灶强化软组织提示局部复发;腹膜后脂肪坏死(6/71,9%)在反相位T1WI上信号丢失,经皮活检组织学证实。
诊断标准与关键数值
- 消融区周边薄环状强化且内部无强化提示消融成功。
- 消融区内沿肾缘的局灶强化软组织提示局部复发。
- 局部复发率T1b为11%(2/19),T1a为2%(1/52)。
- 尿性囊肿(4/71,6%)在监测期间缩小并消失。
临床应用与阅片要点
- 监测CT和MRI应评估消融区周边薄环状强化及内部有无强化以判断消融成功。
- 发现消融区内沿肾缘的局灶强化软组织应提示局部复发。
- 消融后即刻包膜下积气和血肿通常在首次随访前吸收。
- 腹膜后脂肪坏死在反相位T1WI上信号丢失,可经皮活检组织学证实。
局限性
- 本研究为单中心回顾性研究。
- 中位影像随访18个月(IQR 12-28)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To describe the CT and MR imaging findings after microwave ablation of clinical stage 1 renal cell carcinoma (RCC).
METHODS: This single-center retrospective study was performed under a waiver of informed consent. 49 patients (38 M/11F, mean age 66 ± 9.0) with 52 cT1a RCC and 19 patients (10M/9F, mean age 67 ± 9.7) with 19 cT1b RCC were treated with percutaneous microwave ablation between January 2012 and June 2014. The size and volume of the RCC and ablation zone were measured and the kidney, ablation zones and retroperitoneum were assessed at immediate post-procedure CT and surveillance CT and MRI.
RESULTS: Median imaging follow-up was 18 months (IQR 12-28). Ablation zones were heterogeneously hyperintense on T1W and hypointense on T2W MRI and hyperdense at CT. Thin peripheral, but no internal enhancement after contrast administration signified successful ablation zones. Ablation zones decreased in size, but did not resolve during surveillance. Immediate post-procedure subcapsular gas and hematoma (5/71, 7%) resolved prior to first follow-up. Focal, enhancing soft tissue within the ablation zone, invariably along the renal margin, signified local recurrence. Local recurrence rates were higher for T1b (2/19, 11%) compared to T1a (1/52, 2%). Urinomas (4/71, 6%) decreased in size and resolved during surveillance. Retroperitoneal fat necrosis (6/71, 9%), with opposed-phase loss of T1W MRI signal, was confirmed at histology after percutaneous biopsy.
CONCLUSION: CT and MR imaging features after microwave ablation of renal cell carcinoma are predictable and reliably demonstrate treatment success, early and delayed complications, and local recurrences that can guide patient management.
引用
- Wetley KA, Abel EJ, Dreyfuss LD, et al. CT and MR imaging surveillance of stage 1 renal cell carcinoma after microwave ablation. Abdom Radiol (NY). 2020. PMID: 32715335. doi:10.1007/s00261-020-02662-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。